Update shared on 19 Dec 2025
Fair value Decreased 20%Analysts have lowered their 12 month price target for NX Filtration from approximately €4.20 to about €3.38. They cite a slightly higher perceived risk profile, modestly weaker long term margin expectations, and a less demanding future earnings multiple, while maintaining unchanged robust revenue growth assumptions.
Valuation Changes
- Fair Value: reduced moderately from approximately €4.20 to about €3.38 per share.
- Discount Rate: risen slightly from roughly 6.34 percent to about 6.71 percent, reflecting a marginally higher risk assessment.
- Revenue Growth: left unchanged at around 71.34 percent, indicating stable long term top line assumptions.
- Net Profit Margin: lowered slightly from about 8.27 percent to roughly 7.61 percent, pointing to somewhat softer profitability expectations.
- Future P/E: fallen meaningfully from around 66.7 times to about 58.9 times forward earnings, implying a less demanding valuation multiple.
Have other thoughts on NX Filtration?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.